Intestinal Research

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?: Jihye Park, Jae Hee Cheon; Intest Res. 2017;15(3):263-265. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.263
Web of Science 2 Crossref 2; Full text PubReader ePub PDF

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease: Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Yuk-Ming Tsang, Cheng-Yi Wang, Horng-Yuan Wang, Meng-Tzu Weng, Deng-Chyang Wu, Wen-Chieh Wu, Hsu-Heng Yen, Jau-Min Wong; Intest Res. 2017;15(3):266-284. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.266
Web of Science 32 Crossref 32; Full text PubReader ePub PDF

Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease: Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Yuk-Ming Tsang, Cheng-Yi Wang, Horng-Yuan Wang, Meng-Tzu Weng, Deng-Chyang Wu, Wen-Chieh Wu, Hsu-Heng Yen, Jau-Min Wong; Intest Res. 2017;15(3):285-310. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.285
Web of Science 27 Crossref 27; Full text PubReader ePub PDF

Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease: Hyun Jung Lee, Jae Hee Cheon; Intest Res. 2017;15(3):311-317. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.311
Web of Science 17 Crossref 21; Full text PubReader ePub PDF

Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease: Tadakazu Hisamatsu, Mari Hayashida; Intest Res. 2017;15(3):318-327. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.318
Web of Science 18 Crossref 23; Full text PubReader ePub PDF

NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases: Toshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta, Akihiro Nishio, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Yuko Kita, Takako Miyazaki, Masaki Iimuro, Nobuyuki Hida, Kazutoshi Hori, Hiroki Ikeuchi, Shiro Nakamura; Intest Res. 2017;15(3):328-337. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.328
Web of Science 34 Crossref 31; Full text PubReader ePub PDF

Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal Diseases: Young Sun Kim, Sung-Ae Jung, Kang-Moon Lee, Soo Jung Park, Tae Oh Kim, Chang Hwan Choi, Hyun Gun Kim, Won Moon, Chang Mo Moon, Hye Kyoung Song, Soo-Young Na, Suk-Kyun Yang,; Intest Res. 2017;15(3):338-344. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.338
Web of Science 30 Crossref 31; Full text PubReader ePub PDF Supplementary Material

Japanese physicians' attitudes towards enteral nutrition treatment for pediatric patients with Crohn's disease: a questionnaire survey: Takashi Ishige, Takeshi Tomomasa, Hitoshi Tajiri, Atsushi Yoden,; Intest Res. 2017;15(3):345-351. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.345
Web of Science 7 Crossref 7; Full text PubReader ePub PDF

Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease: Daniéla Oliveira Magro, Paulo Gustavo Kotze, Carlos Augusto Real Martinez, Michel Gardere Camargo, Dioze Guadagnini, Antonio Ramos Calixto, Ana Carolina Junqueira Vasques, Maria de Lourdes Setsuko Ayrizono, Bruno Geloneze, José Carlos Pareja, Mario José Saad, Claudio Saddy Rodrigues Coy; Intest Res. 2017;15(3):352-357. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.352
Web of Science 21 Crossref 24; Full text PubReader ePub PDF

Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study: Haruhiko Ogata, Akihiro Ohori, Haruo Nishino, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi; Intest Res. 2017;15(3):358-367. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.358
Web of Science 3 Crossref 4; Full text PubReader ePub PDF

Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind study: Haruhiko Ogata, Nobuo Aoyama, Seiichi Mizushima, Atsushi Hagino, Toshifumi Hibi; Intest Res. 2017;15(3):368-379. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.368
Web of Science 7 Crossref 8; Full text PubReader ePub PDF

Ophthalmologic manifestations in patients with inflammatory bowel disease: Hye Jin Lee, Hyun Joo Song, Jin Ho Jeong, Heung Up Kim, Sun-Jin Boo, Soo-Young Na; Intest Res. 2017;15(3):380-387. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.380
Web of Science 18 Crossref 14; Full text PubReader ePub PDF

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis: Akshita Gupta, Sawan Bopanna, Saurabh Kedia, Dawesh Prakash Yadav, Sandeep Goyal, Saransh Jain, Govind Makharia, Vineet Ahuja; Intest Res. 2017;15(3):388-394. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.388
Web of Science 10 Crossref 8; Full text PubReader ePub PDF

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial: Nagamu Inoue, Kiyonori Kobayashi, Makoto Naganuma, Fumihito Hirai, Morio Ozawa, Dilek Arikan, Bidan Huang, Anne M. Robinson, Roopal B. Thakkar, Toshifumi Hibi; Intest Res. 2017;15(3):395-401. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.395
Web of Science 31 Crossref 30; Full text PubReader ePub PDF

Clinical characteristics of patients with serrated polyposis syndrome in Korea: comparison with Western patients: Eun Ran Kim, Jaryong Jeon, Jin Hee Lee, Yoon Jung Lee, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim; Intest Res. 2017;15(3):402-410. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.402
Web of Science 7 Crossref 4; Full text PubReader ePub PDF

Miss rate of colorectal neoplastic polyps and risk factors for missed polyps in consecutive colonoscopies: Nam Hee Kim, Yoon Suk Jung, Woo Shin Jeong, Hyo-Joon Yang, Soo-Kyung Park, Kyuyong Choi, Dong Il Park; Intest Res. 2017;15(3):411-418. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.411
Web of Science 74 Crossref 60; Full text PubReader ePub PDF

Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers: Harshal Surendra Mandavdhare, Vishal Sharma, Kaushal K Prasad, Amit Kumar, Manish Rathi, Surinder S Rana; Intest Res. 2017;15(3):419-421. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.419
Web of Science 14 Crossref 13; Full text PubReader ePub PDF

Behçet's disease with multiple splenic abscesses in a child: Kyung In Lim, Dong Hwa Yang, Eell Ryoo; Intest Res. 2017;15(3):422-428. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.422
Web of Science 5 Crossref 5; Full text PubReader ePub PDF

Asymptomatic multiple cystic lesions filled with gas in the colon: Ki Bae Kim, Soon Man Yoon; Intest Res. 2017;15(3):429-430. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.429; Full text PubReader ePub PDF

Previous issues